Healthcare & Life Sciences

Singular Bio

United Statesir.invitae.com/news-and-events/press-releases/press-release-details/2019/Invitae-to-Acquire-Singular-Bio-to-Help-Increase-Access-to-Genetic-Screening-in-Early-Pregnancy/default.aspx

acquired

Stage

Investors

About

Singular Bio developed genetic screening technologies to improve access to early pregnancy genetic testing, and was acquired by Invitae to enhance genetic screening capabilities.

Explore Singular Bio's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.